Position
Squarepoint Ops LLC in Mineralys Therapeutics, Inc.
Back to the book · All holders of MLYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$970.5K$36.29 → $27.09
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 246.8K | $8.96M | — | — | — | 0.0% |
| Q1 2026 | 105.5K | $2.86M | $27.09 | −$970.5K | −$5.13M | 0.0% |